- Home
- LGL vs KZR Comparison
LGL vs KZR Comparison
Compare LGL & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGL
- KZR
- Stock Information
- Founded
- LGL 1917
- KZR 2015
- Country
- LGL United States
- KZR United States
- Employees
- LGL N/A
- KZR N/A
- Industry
- LGL Industrial Machinery/Components
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- LGL Technology
- KZR Health Care
- Exchange
- LGL Nasdaq
- KZR Nasdaq
- Market Cap
- LGL 34.1M
- KZR 29.7M
- IPO Year
- LGL N/A
- KZR 2018
- Fundamental
- Price
- LGL $6.65
- KZR $3.92
- Analyst Decision
- LGL
- KZR Hold
- Analyst Count
- LGL 0
- KZR 2
- Target Price
- LGL N/A
- KZR $9.00
- AVG Volume (30 Days)
- LGL 9.6K
- KZR 39.9K
- Earning Date
- LGL 11-12-2025
- KZR 11-11-2025
- Dividend Yield
- LGL N/A
- KZR N/A
- EPS Growth
- LGL N/A
- KZR N/A
- EPS
- LGL 0.04
- KZR N/A
- Revenue
- LGL $4,178,000.00
- KZR N/A
- Revenue This Year
- LGL N/A
- KZR N/A
- Revenue Next Year
- LGL N/A
- KZR N/A
- P/E Ratio
- LGL $164.04
- KZR N/A
- Revenue Growth
- LGL 6.34
- KZR N/A
- 52 Week Low
- LGL $5.50
- KZR $3.56
- 52 Week High
- LGL $9.74
- KZR $9.18
- Technical
- Relative Strength Index (RSI)
- LGL 48.76
- KZR 52.09
- Support Level
- LGL $6.59
- KZR $3.56
- Resistance Level
- LGL $6.80
- KZR $3.96
- Average True Range (ATR)
- LGL 0.23
- KZR 0.20
- MACD
- LGL 0.01
- KZR 0.02
- Stochastic Oscillator
- LGL 50.81
- KZR 66.67
About LGL LGL Group Inc. (The)
LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.